GEF-2 Activators
GEF-2 Activators are a diverse set of chemical compounds that indirectly enhance the functional activity of GEF-2 through various signaling pathways. Forskolin indirectly boosts GEF-2 activity by increasing cAMP levels, which, through PKA activation, may lead to phosphorylation events that enhance GEF-2's GTP exchange function on its target G-proteins. PMA's activation of PKC similarly has the potential to phosphorylate and activate GEF-2, enhancing its ability to regulate signaling pathways. Ionomycin, by raising intracellularcalcium levels, promotes calcium-dependent signaling which can implicate GEF-2 activation. EGCG, by inhibiting specific kinases, may reduce the negative regulation on pathways associated with GEF-2, leading to its functional enhancement. Sphingosine-1-phosphate, through its receptor-mediated actions, could facilitate GEF-2 activity by modulating its interactions with membrane components. LY294002 and U0126, by inhibiting PI3K and MEK1/2 respectively, might cause a compensatory activation of GEF-2 to maintain cellular signaling homeostasis. Thapsigargin and SB203580, through increasing intracellular calcium and inhibiting p38 MAPK, can shift signaling equilibria to favor GEF-2 activation. PD 98059, by reducing ERK phosphorylation, may also promote GEF-2's role in alternative signaling pathways. Go 6983, despite its inhibitory action on PKC, could paradoxically enhance GEF-2 activity through the activation of compensatory signaling mechanisms. Lastly, Anisomycin, by activating SAPKs, could lead to modifications in signaling cascades that enhance GEF-2 function as part of cellular stress responses.
The collective action of these GEF-2 activators on their respective pathways contributes to the modulation and enhancement of GEF-2's activity within the cell. The intricate interplay of kinase inhibition by EGCG, LY294002, and the MEK inhibitors U0126 and PD 98059 highlights the interconnected nature of cellular signaling networks and their capacity to rebalance and enhance certain pathways, such as those involving GEF-2, to maintain homeostasis. The biochemical mechanisms by which S1P and Thapsigargin enhance GEF-2 activity through lipid and calcium signaling demonstrate the complexity of GEF-2 regulation. The potential for PMA and Go 6983 to influence GEF-2 activity through PKC-related pathways suggests a multifaceted role of GEF-2 in cellular signaling. Anisomycin's role in stress response further emphasizes the adaptability of GEF-2 activation in response to cellular stressors. Together, these activators elucidate a network of regulatory mechanisms that, while diverse in nature, converge on the enhancement of GEF-2's role in cellular signaling processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing levels of cAMP. Elevated cAMP leads to the activation of PKA, which can phosphorylate and activate downstream targets including guanine nucleotide exchange factors (GEFs) such as GEF-2, which in turn activates G-proteins involved in various signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC can phosphorylate various substrates including GEFs, potentially enhancing the activity of GEF-2 by increasing its GTP exchange activity on small GTPases. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, which can activate calcium-sensitive enzymes and proteins, potentially leading to the activation of GEF-2 as part of the calcium signaling pathway. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG, a major component of green tea, has been shown to have kinase inhibition properties. This inhibition can affect multiple pathways and potentially enhance GEF-2 activity by reducing negative regulatory influences on GEF-2-associated pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors. Signal transduction through these receptors can lead to the activation of GEFs, including GEF-2, by modulating their interaction with membrane lipids and associated proteins. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor. Inhibition of PI3K can lead to alterations in downstream signaling pathways, potentially leading to a compensatory activation of GEF-2 to maintain signaling homeostasis. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which are part of the MAPK/ERK pathway. Inhibition of this pathway can lead to a rebalancing of signaling networks, potentially enhancing the activation of GEF-2 as a compensatory mechanism. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium levels, which can activate calcium-dependent proteins and potentially increase GEF-2 activity as part of the calcium signaling response. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK. Inhibition of p38 can shift signaling dynamics, potentially enhancing the activity of GEF-2 by allowing for increased activity of alternative signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD 98059 is an inhibitor of MEK, which can lead to a decrease in ERK phosphorylation. This decrease may activate alternative signaling pathways or proteins, potentially enhancing the activity of GEF-2. | ||||||